Resistance to CD95/Fas-induced and ceramide-mediated apoptosis of human melanoma cells is caused by a defective mitochondrial cytochrome c release

FEBS Letters

Volumn 473, Issue 1, 2000, Pages 27-32

  Raisova, Monika ^a   Bektas, Meryem ^a   Wieder, Thomas ^b   Daniel, Peter ^b   Eberle, Jürgen ^a   Orfanos, Constantin E ^a   Geilen, Christoph C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b University Medicine   (Germany)

Author keywords

CD95 Fas; Cytochrome c release; Melanoma; Mitochondrion; Signaling

Indexed keywords

CASPASE 3; CASPASE 9; CERAMIDE; CYTOCHROME C; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; MITOCHONDRIAL ENZYME; MONOCLONAL ANTIBODY; N ACETYLSPHINGOSINE; RECEPTOR; SPHINGOMYELIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL TYPE; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CYTOCHROME C GROUP; DNA FRAGMENTATION; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; FAS LIGAND PROTEIN; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GENE EXPRESSION; HUMANS; HYDROLYSIS; MELANOMA; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; RNA, MESSENGER; SIGNAL TRANSDUCTION; SPHINGOMYELINS; SPHINGOSINE; TUMOR CELLS, CULTURED;

EID: 0034604053     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(00)01491-5     Document Type: Article

References (41)

1. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. Cell. 66:1991;233-243.
2. Boldin M.P., Goncharov T.M., Goltsev Y.V., Wallach D. Cell. 85:1996;803-815.
3. Kischkel F.C., Hellbardt S., Behrmann I., Germer M., Pawlita M., Krammer P.H., Peter M.E. EMBO J. 14:1995;5579-5588.
4. Ashkenazi A., Dixit V.M. Science. 281:1998;1305-1308.
5. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. EMBO J. 17:1998;1675-1687.
6. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., Wang X. Cell. 91:1997;479-489.
7. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., Wang X. Science. 275:1997;1129-1132.
8. Hannun Y.A. J. Biol. Chem. 269:1994;3125-3128.
9. Jarvis W.D., Grant S., Kolesnick R.N. Clin. Cancer Res. 2:1996;1-6.
10. Geilen C.C., Wieder T., Orfanos C.E. Arch. Dermatol. Res. 289:1997;559-566.
11. Riboni L., Viani P., Bassi R., Prinetti A., Tettamanti G. Prog. Lipid Res. 36:1997;153-195.
12. Wieder T., Geilen C.C., Kolter T., Sadeghlar F., Sandhoff K., Brossmer R., Ihrig P., Perry D., Orfanos C.E., Hannun Y.A. FEBS Lett. 411:1997;260-264.
13. Anjum R., Ali A.M., Begum Z., Vanaja J., Khar A. FEBS Lett. 439:1998;81-84.
14. Griffith T.S., Chin W.A., Jackson G.C., Lynch D.H., Kubin M.Z. J. Immunol. 161:1998;2833-2840.
15. Giard D.J., Aaronson S.A., Todaro G.J., Arnstein P., Kersey J.H., Dosik H., Parks W.P. J. Natl. Cancer Inst. 51:1973;1417-1423.
16. Lockshin A., Giovanella B.C., De Ipolyi P.D., Williams L.J. Jr., Mendoza J.T., Yim S.O., Stehlin J.S. Jr. Cancer Res. 45:1985;345-350.
17. Aubert C., Rouge F., Reillaudou M., Metge P. Int. J. Cancer. 54:1993;784-792.
18. Holzmann B., Lehmann J.M., Ziegler-Heitbrock H.W., Funke I., Riethmuller G., Johnson J.P. Int. J. Cancer. 41:1988;542-547.
19. Bruggen J., Macher E., Sorg C. Cancer Immunol. Immunother. 10:1981;121-127.
20. Bean M.A., Bloom B.R., Herberman R.B., Old L.J., Oettgen H.F., Klein G., Terry W.D. Cancer Res. 35:1975;2902-2913.
21. Carey T.E., Takahashi T., Resnick L.A., Oettgen H.F., Old L.J. Proc. Natl. Acad. Sci. USA. 73:1976;3278-3282.
22. Wieder T., Orfanos C.E., Geilen C.C. J. Biol. Chem. 273:1998;11025-11031.
23. Geilen C.C., Bektas M., Wieder T., Kodelja V., Goerdt S., Orfanos C.E. J. Biol. Chem. 272:1997;8997-9001.
24. Geilen C.C., Bektas M., Wieder T., Orfanos C.E. FEBS Lett. 378:1996;88-92.
25. Jayadev S., Linardic C.M., Hannun Y.A. J. Biol. Chem. 269:1994;5757-5763.
26. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Cell. 86:1996;147-157.
27. Wieprecht T., Dathe M., Schumann M., Krause E., Beyermann M., Bienert M. Biochemistry. 35:1996;10844-10853.
28. Houghton J.A., Harwood F.G., Gibson A.A., Tillman D.M. Clin. Cancer Res. 3:1997;2205-2209.
29. Cifone M.G., De Maria R., Roncaioli P., Rippo M.R., Azuma M., Lanier L.L., Santoni A., Testi R. J. Exp. Med. 177:1993;1547-1552.
30. Jeckel D., Wieland F. Adv. Lipid Res. 26:1993;143-160.
31. Ghafourifar P., Klein S.D., Schucht O., Schenk U., Pruschy M., Rocha S., Richter C. J. Biol. Chem. 274:1999;6080-6084.
32. Owen-Schaub L.B., Radinsky R., Kruzel E., Berry K., Yonehara S. Cancer Res. 54:1994;1580-1586.
33. Shin M.S., Park W.S., Kim S.Y., Kim H.S., Kang S.J., Song K.Y., Park J.Y., Dong S.M., Pi J.H., Oh R.R., Lee J.Y., Yoo N.J., Lee S.H. Am. J. Pathol. 154:1999;1785-1791.
34. Adams J.M., Cory S. Science. 281:1998;1322-1326.
35. Bargou R.C., Daniel P.T., Mapara M.Y., Bommert K., Wagener C., Kallinich B., Royer H.D., Dörken B. Int. J. Cancer. 60:1995;854-859.
36. Takei H., Oyama T., Iino Y., Horiguchi J., Hikino T., Maemura M., Nagaoka H., Iijima K., Yokoe T., Nakajima T., Morishita Y. Oncol. Rep. 6:1999;575-581.
37. Bargou R.C., Wagener C., Bommert K., Mapara M.Y., Daniel P.T., Arnold W., Dietel M., Guski H., Feller A., Royer H.D., Dörken B. J. Clin. Invest. 97:1996;2651-2659.
38. Selzer E., Schlagbauer-Wadl H., Okamoto I., Pehamberger H., Potter R., Jansen B. Melanoma Res. 8:1998;197-203.
39. Plettenberg A., Ballaun C., Pammer J., Mildner M., Strunk D., Weninger W., Tschachler E. Am. J. Pathol. 146:1995;651-659.
40. Hsu S.-C., Wu C.C., Luh T.-Y., Chou C.-K., Han S.-H., Lai M.-Z. Blood. 91:1998;2658-2663.
41. Sillence D.J., Allen D. Biochem. J. 324:1997;29-35.